DISEASE-SPECIFIC COSTS OF CARE AND SURVIVAL AMONG MEDICARE-ENROLLED PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

被引:0
|
作者
Zeidan, A. [1 ]
Wang, R. [2 ]
Davidoff, A. [2 ]
Gore, S. [1 ]
Gross, C. [2 ]
Ma, X. [2 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale Univ, Sch Publ Hlth, New Haven, CT USA
关键词
D O I
10.1016/S0145-2126(15)30045-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
44
引用
收藏
页码:S20 / S20
页数:1
相关论文
共 50 条
  • [1] Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes
    Zeidan, Amer M.
    Wang, Rong
    Davidoff, Amy J.
    Ma, Shuangge
    Zhao, Yinjun
    Gore, Steven D.
    Gross, Cary P.
    Ma, Xiaomei
    [J]. CANCER, 2016, 122 (10) : 1598 - 1607
  • [2] Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US)
    Zeidan, Amer M.
    Wang, Rong
    Davidoff, Amy J.
    Gore, Steven D.
    Soulos, Pamela R.
    Huntington, Scott F.
    Gross, Cary P.
    Ma, Xiaomei
    [J]. BLOOD, 2015, 126 (23)
  • [3] Development of a disease-specific measure of quality of life in myelodysplastic syndromes (MDS): The "QUALMS-1".
    Abel, Gregory Alan
    Lee, Stephanie
    Stone, Richard M.
    Steensma, David P.
    Young, Nancy
    Houk, Alice
    Hastings, B. Taylor
    Martins, Yolanda
    Klaassen, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare
    Sheehan, Deirdre F.
    Criss, Steven D.
    Chen, Yufan
    Eckel, Andrew
    Palazzo, Lauren
    Tramontano, Angela C.
    Hur, Chin
    Cipriano, Lauren E.
    Kong, Chung Yin
    [J]. CANCER MEDICINE, 2019, 8 (01): : 94 - 103
  • [5] Relationship between Clinical Conditions and Use of Veterans Affairs Health Care among Medicare-Enrolled Veterans
    Petersen, Laura A.
    Byrne, Margaret M.
    Daw, Christina N.
    Hasche, Jennifer
    Reis, Brian
    Pietz, Kenneth
    [J]. HEALTH SERVICES RESEARCH, 2010, 45 (03) : 762 - 791
  • [6] ECONOMIC BURDEN OF MYELODYSPLASTIC SYNDROMES AMONG US MEDICARE BENEFICIARIES: INCREASED COSTS IN TRANSFUSION DEPENDENT PATIENTS
    Goldberg, S. L.
    Chen, E.
    Corral, M.
    Guo, A.
    Laouri, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A29 - A29
  • [7] Overall survival (OS) by line of therapy (LOT) in Medicare-enrolled glioblastoma multiforme (GBM) patients (pts).
    Aly, Abdalla
    Singh, Prianka
    Korytowsky, Beata
    Dastani, Homa
    Ling, Lisa
    Botteman, Marc
    Norden, Andrew David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [9] Prevalence of cardiac disease among a US medicare population with myelodysplastic syndromes
    Goldberg, S. L.
    Mody-Patel, N.
    Warnock, N.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S103 - S103
  • [10] Thrombocytopenia Predicts for Poor Survival In Patients with Lower Risk Myelodysplastic Syndromes (MDS)
    Cruz, Raymond
    Galili, Naomi
    Khan, Ghulam Sajjad
    Raza, Azra
    [J]. BLOOD, 2010, 116 (21) : 1638 - 1638